IJTLD Open
International Union Against Tuberculosis and Lung Disease (The Union)
Journal websitePeer review: Other
Evaluation status available after sign-in
About the journal
IJTLD Open is an open-access journal published by International Union Against Tuberculosis and Lung Disease (The Union) in France, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,100 EUR. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- International Union Against Tuberculosis and Lung Disease (The Union)
- ISSN
- 3005-7590
- Country
- France
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,100 EUR
- Articles in DOAJ
- 329
- Declared review time
- 8 weeks
- Declared peer-review model
- other
- Official website
- https://journals.theunion.org/content/ijtldo
Index listings
- DOAJ · 2025-01-08
- Indexing
- DOAJ
- APC
- 3,100 EUR
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
329
Most recent article
last month
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
297
Last recorded publication year
2026
Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
10
i10-index
15
From OpenAlex open data (CC0).
Editorial & policy11
- Added to DOAJ
- 2025-01-08
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 3%
- Enrolled in Crossref Similarity Check
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918803487706676
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
LCC codes
RC705-779
Subject areas
- Tuberculosis Research and Epidemiology
- Tuberculosis Research and Epidemiology
- Tuberculosis Research and Epidemiology
- Infectious Diseases and Tuberculosis
- Diagnosis and treatment of tuberculosis
- Diagnosis and treatment of tuberculosis
- Infectious Diseases and Tuberculosis
- Infectious Diseases and Tuberculosis
Show all subjects (75)
- HIV, TB, and STIs Epidemiology
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumocystis jirovecii pneumonia detection and treatment
- HIV/AIDS Research and Interventions
- Mycobacterium research and diagnosis
- Mycobacterium research and diagnosis
- HIV/AIDS Research and Interventions
- Mycobacterium research and diagnosis
- Diagnosis and treatment of tuberculosis
- Healthcare Systems and Reforms
- HIV/AIDS Research and Interventions
- Healthcare Facilities Design and Sustainability
- Healthcare Facilities Design and Sustainability
- Pneumonia and Respiratory Infections
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pneumonia and Respiratory Infections
- Health Systems, Economic Evaluations, Quality of Life
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotic Resistance in Bacteria
- Lung Cancer Diagnosis and Treatment
- Immune responses and vaccinations
- Medication Adherence and Compliance
- Immune responses and vaccinations
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Chronic Disease Management Strategies
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Chronic Disease Management Strategies
- HIV/AIDS drug development and treatment
- HIV, Drug Use, Sexual Risk
- HIV, Drug Use, Sexual Risk
- HIV/AIDS drug development and treatment
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Antibiotic Use and Resistance
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Medical Practices and Rehabilitation
- Healthcare Systems and Reforms
- Actinomycetales infections and treatment
- Healthcare Systems and Reforms
- COVID-19 diagnosis using AI
- Public Health Policies and Education
- COVID-19 diagnosis using AI
- Pharmaceutical studies and practices
- Clinical Laboratory Practices and Quality Control
- Asthma and respiratory diseases
- Global Maternal and Child Health
- Leprosy Research and Treatment
- Global Maternal and Child Health
- Asthma and respiratory diseases
- Child Nutrition and Water Access
- Leprosy Research and Treatment
- Infectious Diseases and Mycology
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Smoking Behavior and Cessation
- Asthma and respiratory diseases
- COVID-19 Clinical Research Studies
- Child Nutrition and Water Access
- Poverty, Education, and Child Welfare
- Infectious Diseases and Mycology
- Mobile Health and mHealth Applications
- Bipolar Disorder and Treatment
- Emergency and Acute Care Studies
- Emergency and Acute Care Studies
- Bipolar Disorder and Treatment
Keywords (DOAJ)
- tuberculosis
- covid 19
- respiratory diseases
- pneumonia
- infectious diseases
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ